Table 1:

Patient demographics and comparison between patients with and without non-cancer-related adverse events within 1 year

CharacteristicsAll cases (n = 460)Non-cancer-related adverse events within 1 year
P-value
No (n = 366) (84%)aYes (n = 94) (16%)a
Age (years)71 (64–76)70 (63–46)74 (69–78)0.003
Sex
 Male248 (54)183 (50)65 (69)0.001
 Female212 (46)183 (50)29 (31)
BMI (kg/m2)23 (20–25)23 (21–25)22 (20–25)0.27
Smoking history
 Never205 (44)172 (47)33 (35)0.048
 Former242 (53)186 (51)56 (60)
 Current13 (3)8 (2)5 (5)
Hypertension
 No241 (52)191 (52)50 (53)0.86
 Yes219 (48)175 (48)44 (47)
Coronary artery disease
 No418 (91)338 (92)80 (85)0.030
 Yes42 (9)28 (8)14 (15)
Diabetes mellitus
 No365 (79)291 (80)74 (79)0.87
 Yes95 (21)75 (20)20 (21)
History of atrial fibrillation
 No433 (94)346 (95)87 (93)0.47
 Yes27 (6)20 (5)7 (7)
Chemotherapy
 No448 (97)357 (98)91 (97)0.69
 Yes12 (3)9 (2)3 (3)
BNP (pg/ml)23 (13–41)22 (12–38)31 (17–56)0.002
%FEV1 (%)99 (86–113)100 (88–113)90 (77–110)0.002
Surgical approach
 MIS382 (83)312 (85)70 (75)0.013
 Thoracotomy78 (17)54 (15)24 (25)
Surgery
 Segmentectomy162 (35)135 (37)27 (29)0.14
 Lobectomy298 (65)231 (63)67 (71)
Number of resected subsegments6 (4–10)6 (4–10)10 (6–10)0.003
POAF
 No421 (92)342 (93)79 (84)0.004
 Yes39 (8)24 (7)15 (16)
CharacteristicsAll cases (n = 460)Non-cancer-related adverse events within 1 year
P-value
No (n = 366) (84%)aYes (n = 94) (16%)a
Age (years)71 (64–76)70 (63–46)74 (69–78)0.003
Sex
 Male248 (54)183 (50)65 (69)0.001
 Female212 (46)183 (50)29 (31)
BMI (kg/m2)23 (20–25)23 (21–25)22 (20–25)0.27
Smoking history
 Never205 (44)172 (47)33 (35)0.048
 Former242 (53)186 (51)56 (60)
 Current13 (3)8 (2)5 (5)
Hypertension
 No241 (52)191 (52)50 (53)0.86
 Yes219 (48)175 (48)44 (47)
Coronary artery disease
 No418 (91)338 (92)80 (85)0.030
 Yes42 (9)28 (8)14 (15)
Diabetes mellitus
 No365 (79)291 (80)74 (79)0.87
 Yes95 (21)75 (20)20 (21)
History of atrial fibrillation
 No433 (94)346 (95)87 (93)0.47
 Yes27 (6)20 (5)7 (7)
Chemotherapy
 No448 (97)357 (98)91 (97)0.69
 Yes12 (3)9 (2)3 (3)
BNP (pg/ml)23 (13–41)22 (12–38)31 (17–56)0.002
%FEV1 (%)99 (86–113)100 (88–113)90 (77–110)0.002
Surgical approach
 MIS382 (83)312 (85)70 (75)0.013
 Thoracotomy78 (17)54 (15)24 (25)
Surgery
 Segmentectomy162 (35)135 (37)27 (29)0.14
 Lobectomy298 (65)231 (63)67 (71)
Number of resected subsegments6 (4–10)6 (4–10)10 (6–10)0.003
POAF
 No421 (92)342 (93)79 (84)0.004
 Yes39 (8)24 (7)15 (16)

Data are shown as number (%) or median (25–75 percentiles).

a

Percentages among all 460 patients.

BMI: body mass index; BNP: brain natriuretic peptide; %FEV1: percentage-predicted forced expiratory volume in 1 s; MIS: minimally invasive surgery; POAF: postoperative atrial fibrillation.

The bold font indicates statistical significance.

Table 1:

Patient demographics and comparison between patients with and without non-cancer-related adverse events within 1 year

CharacteristicsAll cases (n = 460)Non-cancer-related adverse events within 1 year
P-value
No (n = 366) (84%)aYes (n = 94) (16%)a
Age (years)71 (64–76)70 (63–46)74 (69–78)0.003
Sex
 Male248 (54)183 (50)65 (69)0.001
 Female212 (46)183 (50)29 (31)
BMI (kg/m2)23 (20–25)23 (21–25)22 (20–25)0.27
Smoking history
 Never205 (44)172 (47)33 (35)0.048
 Former242 (53)186 (51)56 (60)
 Current13 (3)8 (2)5 (5)
Hypertension
 No241 (52)191 (52)50 (53)0.86
 Yes219 (48)175 (48)44 (47)
Coronary artery disease
 No418 (91)338 (92)80 (85)0.030
 Yes42 (9)28 (8)14 (15)
Diabetes mellitus
 No365 (79)291 (80)74 (79)0.87
 Yes95 (21)75 (20)20 (21)
History of atrial fibrillation
 No433 (94)346 (95)87 (93)0.47
 Yes27 (6)20 (5)7 (7)
Chemotherapy
 No448 (97)357 (98)91 (97)0.69
 Yes12 (3)9 (2)3 (3)
BNP (pg/ml)23 (13–41)22 (12–38)31 (17–56)0.002
%FEV1 (%)99 (86–113)100 (88–113)90 (77–110)0.002
Surgical approach
 MIS382 (83)312 (85)70 (75)0.013
 Thoracotomy78 (17)54 (15)24 (25)
Surgery
 Segmentectomy162 (35)135 (37)27 (29)0.14
 Lobectomy298 (65)231 (63)67 (71)
Number of resected subsegments6 (4–10)6 (4–10)10 (6–10)0.003
POAF
 No421 (92)342 (93)79 (84)0.004
 Yes39 (8)24 (7)15 (16)
CharacteristicsAll cases (n = 460)Non-cancer-related adverse events within 1 year
P-value
No (n = 366) (84%)aYes (n = 94) (16%)a
Age (years)71 (64–76)70 (63–46)74 (69–78)0.003
Sex
 Male248 (54)183 (50)65 (69)0.001
 Female212 (46)183 (50)29 (31)
BMI (kg/m2)23 (20–25)23 (21–25)22 (20–25)0.27
Smoking history
 Never205 (44)172 (47)33 (35)0.048
 Former242 (53)186 (51)56 (60)
 Current13 (3)8 (2)5 (5)
Hypertension
 No241 (52)191 (52)50 (53)0.86
 Yes219 (48)175 (48)44 (47)
Coronary artery disease
 No418 (91)338 (92)80 (85)0.030
 Yes42 (9)28 (8)14 (15)
Diabetes mellitus
 No365 (79)291 (80)74 (79)0.87
 Yes95 (21)75 (20)20 (21)
History of atrial fibrillation
 No433 (94)346 (95)87 (93)0.47
 Yes27 (6)20 (5)7 (7)
Chemotherapy
 No448 (97)357 (98)91 (97)0.69
 Yes12 (3)9 (2)3 (3)
BNP (pg/ml)23 (13–41)22 (12–38)31 (17–56)0.002
%FEV1 (%)99 (86–113)100 (88–113)90 (77–110)0.002
Surgical approach
 MIS382 (83)312 (85)70 (75)0.013
 Thoracotomy78 (17)54 (15)24 (25)
Surgery
 Segmentectomy162 (35)135 (37)27 (29)0.14
 Lobectomy298 (65)231 (63)67 (71)
Number of resected subsegments6 (4–10)6 (4–10)10 (6–10)0.003
POAF
 No421 (92)342 (93)79 (84)0.004
 Yes39 (8)24 (7)15 (16)

Data are shown as number (%) or median (25–75 percentiles).

a

Percentages among all 460 patients.

BMI: body mass index; BNP: brain natriuretic peptide; %FEV1: percentage-predicted forced expiratory volume in 1 s; MIS: minimally invasive surgery; POAF: postoperative atrial fibrillation.

The bold font indicates statistical significance.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close